Report Detail
Global Human Coagulation Factor VIII Market Growth 2019-2024
- RnM2906396 |
- 08 February, 2019 |
- Global |
- 161 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.
North America is the largest consumption market of Human Coagulation Factor VIII, with sales market share nearly 46%. And the production market share of Human Coagulation Factor VIII is 58%. The manufacturers of Human Coagulation Factor VIII in North America have big and medium scale.
The second place is Europe, following North America with the sales market share of 36% and the production market share over 28%. Many European players have plants in USA due to rich plasma source. So there are a large number of Human Coagulation Factor VIIIs for import from other regions.
Asia is another important market of Human Coagulation Factor VIII, enjoying 10% production market share and 11% sales market share. Especially in China, the sales and price of Factor VIII are controlled by country, and the price in China is different from other regions.
Main players are from USA and Europe, like Baxter, Bayer, and they have many plants in other regions. China also can supply Human Coagulation Factor VIII, but the products are mainly consumed in China.
Market competition is intense. Baxter, Bayer, CSL, Pfizer, Grifols, etc. are the leaders of the industry, and hold key technologies, with high-end customers, have been formed in the monopoly position in the industry. However, with further expanding market, there will be more manufactures in the future.
According to this study, over the next five years the Human Coagulation Factor VIII market will register a 2.8% CAGR in terms of revenue, the global market size will reach US$ 8770 million by 2024, from US$ 7440 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Coagulation Factor VIII business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Coagulation Factor VIII market by product type, application, key manufacturers and key regions and countries.
This study considers the Human Coagulation Factor VIII value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Recombinant Factor VIII
Plasma-derived Factor VIII
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hemophilia A
Spontanous / Trauma
Surgical
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Human Coagulation Factor VIII consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Human Coagulation Factor VIII market by identifying its various subsegments.
Focuses on the key global Human Coagulation Factor VIII manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Coagulation Factor VIII with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Human Coagulation Factor VIII submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Human Coagulation Factor VIII Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Human Coagulation Factor VIII Consumption 2014-2024
- 2.1.2 Human Coagulation Factor VIII Consumption CAGR by Region
- 2.2 Human Coagulation Factor VIII Segment by Type
- 2.2.1 Recombinant Factor VIII
- 2.2.2 Plasma-derived Factor VIII
- 2.3 Human Coagulation Factor VIII Consumption by Type
- 2.3.1 Global Human Coagulation Factor VIII Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Human Coagulation Factor VIII Sale Price by Type (2014-2019)
- 2.4 Human Coagulation Factor VIII Segment by Application
- 2.4.1 Hemophilia A
- 2.4.2 Spontanous / Trauma
- 2.4.3 Surgical
- 2.4.4 Other
- 2.5 Human Coagulation Factor VIII Consumption by Application
- 2.5.1 Global Human Coagulation Factor VIII Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Human Coagulation Factor VIII Value and Market Share by Application (2014-2019)
- 2.5.3 Global Human Coagulation Factor VIII Sale Price by Application (2014-2019)
3 Global Human Coagulation Factor VIII by Players
- 3.1 Global Human Coagulation Factor VIII Sales Market Share by Players
- 3.1.1 Global Human Coagulation Factor VIII Sales by Players (2017-2019)
- 3.1.2 Global Human Coagulation Factor VIII Sales Market Share by Players (2017-2019)
- 3.2 Global Human Coagulation Factor VIII Revenue Market Share by Players
- 3.2.1 Global Human Coagulation Factor VIII Revenue by Players (2017-2019)
- 3.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Players (2017-2019)
- 3.3 Global Human Coagulation Factor VIII Sale Price by Players
- 3.4 Global Human Coagulation Factor VIII Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Human Coagulation Factor VIII Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Human Coagulation Factor VIII Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Human Coagulation Factor VIII by Regions
- 4.1 Human Coagulation Factor VIII by Regions
- 4.1.1 Global Human Coagulation Factor VIII Consumption by Regions
- 4.1.2 Global Human Coagulation Factor VIII Value by Regions
- 4.2 Americas Human Coagulation Factor VIII Consumption Growth
- 4.3 APAC Human Coagulation Factor VIII Consumption Growth
- 4.4 Europe Human Coagulation Factor VIII Consumption Growth
- 4.5 Middle East & Africa Human Coagulation Factor VIII Consumption Growth
5 Americas
- 5.1 Americas Human Coagulation Factor VIII Consumption by Countries
- 5.1.1 Americas Human Coagulation Factor VIII Consumption by Countries (2014-2019)
- 5.1.2 Americas Human Coagulation Factor VIII Value by Countries (2014-2019)
- 5.2 Americas Human Coagulation Factor VIII Consumption by Type
- 5.3 Americas Human Coagulation Factor VIII Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Human Coagulation Factor VIII Consumption by Countries
- 6.1.1 APAC Human Coagulation Factor VIII Consumption by Countries (2014-2019)
- 6.1.2 APAC Human Coagulation Factor VIII Value by Countries (2014-2019)
- 6.2 APAC Human Coagulation Factor VIII Consumption by Type
- 6.3 APAC Human Coagulation Factor VIII Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Human Coagulation Factor VIII by Countries
- 7.1.1 Europe Human Coagulation Factor VIII Consumption by Countries (2014-2019)
- 7.1.2 Europe Human Coagulation Factor VIII Value by Countries (2014-2019)
- 7.2 Europe Human Coagulation Factor VIII Consumption by Type
- 7.3 Europe Human Coagulation Factor VIII Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Human Coagulation Factor VIII by Countries
- 8.1.1 Middle East & Africa Human Coagulation Factor VIII Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Human Coagulation Factor VIII Value by Countries (2014-2019)
- 8.2 Middle East & Africa Human Coagulation Factor VIII Consumption by Type
- 8.3 Middle East & Africa Human Coagulation Factor VIII Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Human Coagulation Factor VIII Distributors
- 10.3 Human Coagulation Factor VIII Customer
11 Global Human Coagulation Factor VIII Market Forecast
- 11.1 Global Human Coagulation Factor VIII Consumption Forecast (2019-2024)
- 11.2 Global Human Coagulation Factor VIII Forecast by Regions
- 11.2.1 Global Human Coagulation Factor VIII Forecast by Regions (2019-2024)
- 11.2.2 Global Human Coagulation Factor VIII Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Human Coagulation Factor VIII Forecast by Type
- 11.8 Global Human Coagulation Factor VIII Forecast by Application
12 Key Players Analysis
- 12.1 Shire (Baxter)
- 12.1.1 Company Details
- 12.1.2 Human Coagulation Factor VIII Product Offered
- 12.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Shire (Baxter) News
- 12.2 Bayer
- 12.2.1 Company Details
- 12.2.2 Human Coagulation Factor VIII Product Offered
- 12.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Bayer News
- 12.3 CSL
- 12.3.1 Company Details
- 12.3.2 Human Coagulation Factor VIII Product Offered
- 12.3.3 CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 CSL News
- 12.4 Pfizer
- 12.4.1 Company Details
- 12.4.2 Human Coagulation Factor VIII Product Offered
- 12.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Pfizer News
- 12.5 Grifols
- 12.5.1 Company Details
- 12.5.2 Human Coagulation Factor VIII Product Offered
- 12.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Grifols News
- 12.6 Biogen
- 12.6.1 Company Details
- 12.6.2 Human Coagulation Factor VIII Product Offered
- 12.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Biogen News
- 12.7 Octapharma
- 12.7.1 Company Details
- 12.7.2 Human Coagulation Factor VIII Product Offered
- 12.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Octapharma News
- 12.8 NovoNordisk
- 12.8.1 Company Details
- 12.8.2 Human Coagulation Factor VIII Product Offered
- 12.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 NovoNordisk News
- 12.9 Greencross
- 12.9.1 Company Details
- 12.9.2 Human Coagulation Factor VIII Product Offered
- 12.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Greencross News
- 12.10 Kedrion
- 12.10.1 Company Details
- 12.10.2 Human Coagulation Factor VIII Product Offered
- 12.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Kedrion News
- 12.11 BPL
- 12.12 Hualan Bio
- 12.13 RAAS
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Human Coagulation Factor VIII . Industry analysis & Market Report on Human Coagulation Factor VIII is a syndicated market report, published as Global Human Coagulation Factor VIII Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Human Coagulation Factor VIII market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
